Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Executive functioning as a predictor of stroke rehabilitation outcomes.

Shea-Shumsky NB, Schoeneberger S, Grigsby J.

Clin Neuropsychol. 2019 Jul;33(5):854-872. doi: 10.1080/13854046.2018.1546905. Epub 2019 Jan 24.

PMID:
30676883
2.

3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats.

Hake HS, Davis JKP, Wood RR, Tanner MK, Loetz EC, Sanchez A, Ostrovskyy M, Oleson EB, Grigsby J, Doblin R, Greenwood BN.

Physiol Behav. 2019 Feb 1;199:343-350. doi: 10.1016/j.physbeh.2018.12.007. Epub 2018 Dec 4.

PMID:
30529341
3.

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.

Ot'alora G M, Grigsby J, Poulter B, Van Derveer JW 3rd, Giron SG, Jerome L, Feduccia AA, Hamilton S, Yazar-Klosinski B, Emerson A, Mithoefer MC, Doblin R.

J Psychopharmacol. 2018 Dec;32(12):1295-1307. doi: 10.1177/0269881118806297. Epub 2018 Oct 29.

4.

Presence of Middle Cerebellar Peduncle Sign in FMR1 Premutation Carriers Without Tremor and Ataxia.

Famula JL, McKenzie F, McLennan YA, Grigsby J, Tassone F, Hessl D, Rivera SM, Martinez-Cerdeno V, Hagerman RJ.

Front Neurol. 2018 Aug 22;9:695. doi: 10.3389/fneur.2018.00695. eCollection 2018.

5.

Visual cycle proteins: Structure, function, and roles in human retinal disease.

Tsin A, Betts-Obregon B, Grigsby J.

J Biol Chem. 2018 Aug 24;293(34):13016-13021. doi: 10.1074/jbc.AW118.003228. Epub 2018 Jul 12.

6.

Right Ventricular Heart Failure from a Cardiac Yolk Sac Tumor.

Isom N, Rali AS, Damjanov I, Hubbard K, Grigsby J, Gupta K.

Am J Case Rep. 2018 Mar 2;19:229-233.

7.

Harnessing centred identity transformation to reduce executive function burden for maintenance of health behaviour change: the Maintain IT model.

Caldwell AE, Masters KS, Peters JC, Bryan AD, Grigsby J, Hooker SA, Wyatt HR, Hill JO.

Health Psychol Rev. 2018 Sep;12(3):231-253. doi: 10.1080/17437199.2018.1437551. Epub 2018 Feb 19. Review.

8.

Autocrine and Paracrine Secretion of Vascular Endothelial Growth Factor in the Pre-Hypoxic Diabetic Retina.

Grigsby JG, Allen DM, Ferrigno AS, Vellanki S, Pouw CE, Hejny WA, Tsin ATC.

Curr Diabetes Rev. 2017;13(2):161-174. doi: 10.2174/1573399812666161007165944. Review.

PMID:
27748176
9.

The fragile X mental retardation 1 gene (FMR1): historical perspective, phenotypes, mechanism, pathology, and epidemiology.

Grigsby J.

Clin Neuropsychol. 2016 Aug;30(6):815-33. doi: 10.1080/13854046.2016.1184652. Epub 2016 Jun 29. Review.

10.

Fragile X-associated tremor/ataxia syndrome: another phenotype of the fragile X gene.

Hessl D, Grigsby J.

Clin Neuropsychol. 2016 Aug;30(6):810-4. doi: 10.1080/13854046.2016.1186661. Epub 2016 Jun 29.

11.

Clinically significant psychiatric symptoms among male carriers of the fragile X premutation, with and without FXTAS, and the mediating influence of executive functioning.

Grigsby J, Brega AG, Bennett RE, Bourgeois JA, Seritan AL, Goodrich GK, Hagerman RJ.

Clin Neuropsychol. 2016 Aug;30(6):944-59. doi: 10.1080/13854046.2016.1185100. Epub 2016 Jun 29.

12.

Update on the Clinical, Radiographic, and Neurobehavioral Manifestations in FXTAS and FMR1 Premutation Carriers.

Hall DA, Robertson E, Shelton AL, Losh MC, Mila M, Moreno EG, Gomez-Anson B, Martínez-Cerdeño V, Grigsby J, Lozano R, Hagerman R, Maria LS, Berry-Kravis E, O'Keefe JA.

Cerebellum. 2016 Oct;15(5):578-86. doi: 10.1007/s12311-016-0799-4. Review.

PMID:
27287737
13.

Memantine Improves Attentional Processes in Fragile X-Associated Tremor/Ataxia Syndrome: Electrophysiological Evidence from a Randomized Controlled Trial.

Yang JC, Rodriguez A, Royston A, Niu YQ, Avar M, Brill R, Simon C, Grigsby J, Hagerman RJ, Olichney JM.

Sci Rep. 2016 Feb 22;6:21719. doi: 10.1038/srep21719.

14.

Managing Problems Before Problems Manage You.

Grigsby J.

J Med Pract Manage. 2015 May-Jun;30(6):393-4.

PMID:
26182705
15.

White matter disease and cognitive impairment in FMR1 premutation carriers.

Filley CM, Brown MS, Onderko K, Ray M, Bennett RE, Berry-Kravis E, Grigsby J.

Neurology. 2015 May 26;84(21):2146-52. doi: 10.1212/WNL.0000000000001612. Epub 2015 Apr 29.

16.

Effects of pioglitazone or exercise in older adults with mild cognitive impairment and insulin resistance: a pilot study.

Hildreth KL, Van Pelt RE, Moreau KL, Grigsby J, Hoth KF, Pelak V, Anderson CA, Parnes B, Kittelson J, Wolfe P, Nakamura T, Linnebur SA, Trujillo JM, Aquilante CL, Schwartz RS.

Dement Geriatr Cogn Dis Extra. 2015 Feb 20;5(1):51-63. doi: 10.1159/000371509. eCollection 2015 Jan-Apr.

17.

The role of microglia in diabetic retinopathy.

Grigsby JG, Cardona SM, Pouw CE, Muniz A, Mendiola AS, Tsin AT, Allen DM, Cardona AE.

J Ophthalmol. 2014;2014:705783. doi: 10.1155/2014/705783. Epub 2014 Aug 31. Review.

18.

The cognitive neuropsychological phenotype of carriers of the FMR1 premutation.

Grigsby J, Cornish K, Hocking D, Kraan C, Olichney JM, Rivera SM, Schneider A, Sherman S, Wang JY, Yang JC.

J Neurodev Disord. 2014;6(1):28. doi: 10.1186/1866-1955-6-28. Epub 2014 Jul 30. Review.

19.

The empirical foundations of telemedicine interventions for chronic disease management.

Bashshur RL, Shannon GW, Smith BR, Alverson DC, Antoniotti N, Barsan WG, Bashshur N, Brown EM, Coye MJ, Doarn CR, Ferguson S, Grigsby J, Krupinski EA, Kvedar JC, Linkous J, Merrell RC, Nesbitt T, Poropatich R, Rheuban KS, Sanders JH, Watson AR, Weinstein RS, Yellowlees P.

Telemed J E Health. 2014 Sep;20(9):769-800. doi: 10.1089/tmj.2014.9981. Epub 2014 Jun 26. Review.

20.

Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial.

Seritan AL, Nguyen DV, Mu Y, Tassone F, Bourgeois JA, Schneider A, Cogswell JB, Cook KR, Leehey MA, Grigsby J, Olichney JM, Adams PE, Legg W, Zhang L, Hagerman PJ, Hagerman RJ.

J Clin Psychiatry. 2014 Mar;75(3):264-71. doi: 10.4088/JCP.13m08546.

21.

Impact of telemedicine on hospital transport, length of stay, and medical outcomes in infants with suspected heart disease: a multicenter study.

Webb CL, Waugh CL, Grigsby J, Busenbark D, Berdusis K, Sahn DJ, Sable CA; American Society of Echocardiography Telemedicine Collaborators’ Group.

J Am Soc Echocardiogr. 2013 Sep;26(9):1090-8. doi: 10.1016/j.echo.2013.05.018. Epub 2013 Jul 13.

PMID:
23860093
22.

Association of serum dehydroepiandrosterone sulfate and cognition in older adults: sex steroid, inflammatory, and metabolic mechanisms.

Hildreth KL, Gozansky WS, Jankowski CM, Grigsby J, Wolfe P, Kohrt WM.

Neuropsychology. 2013 May;27(3):356-363. doi: 10.1037/a0032230.

23.

Phenotypes of hypofrontality in older female fragile X premutation carriers.

Yang JC, Simon C, Niu YQ, Bogost M, Schneider A, Tassone F, Seritan A, Grigsby J, Hagerman PJ, Hagerman RJ, Olichney JM.

Ann Neurol. 2013 Aug;74(2):275-83. doi: 10.1002/ana.23933.

24.

Impairment of executive cognitive control in type 2 diabetes, and its effects on health-related behavior and use of health services.

Tran D, Baxter J, Hamman RF, Grigsby J.

J Behav Med. 2014 Jun;37(3):414-22. doi: 10.1007/s10865-013-9499-4. Epub 2013 Feb 22.

25.

COGNITIVE DYSFUNCTION IN FMR1 PREMUTATION CARRIERS.

Seritan A, Cogswell J, Grigsby J.

Curr Psychiatry Rev. 2013 Feb;9(1):78-84.

26.

Understanding and execution of discharge instructions.

Coleman EA, Chugh A, Williams MV, Grigsby J, Glasheen JJ, McKenzie M, Min SJ.

Am J Med Qual. 2013 Sep-Oct;28(5):383-91. doi: 10.1177/1062860612472931. Epub 2013 Jan 25.

PMID:
23354870
27.

Cognitive decline and cardiometabolic risk among Hispanic and non-Hispanic white adults in the San Luis Valley Health and Aging Study.

Hildreth KL, Grigsby J, Bryant LL, Wolfe P, Baxter J.

J Behav Med. 2014 Apr;37(2):332-42. doi: 10.1007/s10865-013-9491-z. Epub 2013 Jan 18.

PMID:
23329423
28.

Sustaining and realizing the promise of telemedicine.

Bashshur RL, Shannon G, Krupinski EA, Grigsby J.

Telemed J E Health. 2013 May;19(5):339-45. doi: 10.1089/tmj.2012.0282. Epub 2013 Jan 5. No abstract available.

29.

Estrogen-induced retinal endothelial cell proliferation: possible involvement of pigment epithelium-derived factor and phosphoinositide 3-kinase/mitogen-activated protein kinase pathways.

Parvathaneni K, Grigsby JG, Betts BS, Tsin AT.

J Ocul Pharmacol Ther. 2013 Feb;29(1):27-32. doi: 10.1089/jop.2011.0252. Epub 2012 Oct 9.

30.

Neural substrates of executive dysfunction in fragile X-associated tremor/ataxia syndrome (FXTAS): a brain potential study.

Yang JC, Chan SH, Khan S, Schneider A, Nanakul R, Teichholtz S, Niu YQ, Seritan A, Tassone F, Grigsby J, Hagerman PJ, Hagerman RJ, Olichney JM.

Cereb Cortex. 2013 Nov;23(11):2657-66. doi: 10.1093/cercor/bhs251. Epub 2012 Aug 23.

31.

A possible role of acrolein in diabetic retinopathy: involvement of a VEGF/TGFβ signaling pathway of the retinal pigment epithelium in hyperglycemia.

Grigsby J, Betts B, Vidro-Kotchan E, Culbert R, Tsin A.

Curr Eye Res. 2012 Nov;37(11):1045-53. doi: 10.3109/02713683.2012.713152. Epub 2012 Aug 20.

32.

Capturing the fragile X premutation phenotypes: a collaborative effort across multiple cohorts.

Hunter JE, Sherman S, Grigsby J, Kogan C, Cornish K.

Neuropsychology. 2012 Mar;26(2):156-64. doi: 10.1037/a0026799. Epub 2012 Jan 16.

33.

Oxygen therapy for heart attacks.

Grigsby J.

Nurs N Z. 2011 Nov;17(10):20. No abstract available.

PMID:
22216622
34.

The taxonomy of telemedicine.

Bashshur R, Shannon G, Krupinski E, Grigsby J.

Telemed J E Health. 2011 Jul-Aug;17(6):484-94. doi: 10.1089/tmj.2011.0103. Epub 2011 Jun 30.

35.

Effects of tamoxifen versus raloxifene on retinal capillary endothelial cell proliferation.

Grigsby JG, Parvathaneni K, Almanza MA, Botello AM, Mondragon AA, Allen DM, Tsin AT.

J Ocul Pharmacol Ther. 2011 Jun;27(3):225-33. doi: 10.1089/jop.2010.0171. Epub 2011 Mar 17.

36.

Ginsenoside-Rb1 Induces ARPE-19 Proliferation and Reduces VEGF Release.

Betts BS, Parvathaneni K, Yendluri BB, Grigsby J, Tsin AT.

ISRN Ophthalmol. 2012 Jan 4;2011:184295. doi: 10.5402/2011/184295. eCollection 2011.

37.

Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers.

Adams PE, Adams JS, Nguyen DV, Hessl D, Brunberg JA, Tassone F, Zhang W, Koldewyn K, Rivera SM, Grigsby J, Zhang L, Decarli C, Hagerman PJ, Hagerman RJ.

Am J Med Genet B Neuropsychiatr Genet. 2010 Apr 5;153B(3):775-85. doi: 10.1002/ajmg.b.31046.

38.

Enhanced efficiency in helical tomotherapy quality assurance using a custom-designed water-equivalent phantom.

Goddu SM, Mutic S, Pechenaya OL, Chaudhari SR, Garcia-Ramirez J, Rangaraj D, Klein EE, Yang D, Grigsby J, Low DA.

Phys Med Biol. 2009 Oct 7;54(19):5663-74. doi: 10.1088/0031-9155/54/19/001. Epub 2009 Sep 1.

PMID:
19724101
39.

Executive function (capacity for behavioral self-regulation) and decline predicted mortality in a longitudinal study in Southern Colorado.

Amirian E, Baxter J, Grigsby J, Curran-Everett D, Hokanson JE, Bryant LL.

J Clin Epidemiol. 2010 Mar;63(3):307-14. doi: 10.1016/j.jclinepi.2009.06.004. Epub 2009 Aug 27.

40.

Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes.

Clayton R, Ohagen A, Nicol F, Del Vecchio AM, Jonckers TH, Goethals O, Van Loock M, Michiels L, Grigsby J, Xu Z, Zhang YP, Gutshall LL, Cunningham M, Jiang H, Bola S, Sarisky RT, Hertogs K.

Antiviral Res. 2009 Nov;84(2):142-9. doi: 10.1016/j.antiviral.2009.08.003. Epub 2009 Aug 20.

PMID:
19699239
41.

National telemedicine initiatives: essential to healthcare reform.

Bashshur RL, Shannon GW, Krupinski EA, Grigsby J, Kvedar JC, Weinstein RS, Sanders JH, Rheuban KS, Nesbitt TS, Alverson DC, Merrell RC, Linkous JD, Ferguson AS, Waters RJ, Stachura ME, Ellis DG, Antoniotti NM, Johnston B, Doarn CR, Yellowlees P, Normandin S, Tracy J.

Telemed J E Health. 2009 Jul-Aug;15(6):600-10. doi: 10.1089/tmj.2009.9960. No abstract available.

42.

A review of fragile X premutation disorders: expanding the psychiatric perspective.

Bourgeois JA, Coffey SM, Rivera SM, Hessl D, Gane LW, Tassone F, Greco C, Finucane B, Nelson L, Berry-Kravis E, Grigsby J, Hagerman PJ, Hagerman RJ.

J Clin Psychiatry. 2009 Jun;70(6):852-62. doi: 10.4088/JCP.08m04476. Epub 2009 May 5. Review.

43.

Functional status of men with the fragile X premutation, with and without the tremor/ataxia syndrome (FXTAS).

Brega AG, Reynolds A, Bennett RE, Leehey MA, Bounds LS, Cogswell JB, Hagerman RJ, Hagerman PJ, Grigsby J.

Int J Geriatr Psychiatry. 2009 Oct;24(10):1101-9. doi: 10.1002/gps.2231.

44.

Better transitions: improving comprehension of discharge instructions.

Chugh A, Williams MV, Grigsby J, Coleman EA.

Front Health Serv Manage. 2009 Spring;25(3):11-32. Review.

PMID:
19382514
45.

Nurses' assessment of rehabilitation potential and prediction of functional status at discharge from inpatient rehabilitation.

Myers JS, Grigsby J, Teel CS, Kramer AM.

Int J Rehabil Res. 2009 Sep;32(3):264-6. doi: 10.1097/MRR.0b013e32832a62c2.

PMID:
19318974
46.

The primary cognitive deficit among males with fragile X-associated tremor/ataxia syndrome (FXTAS) is a dysexecutive syndrome.

Brega AG, Goodrich G, Bennett RE, Hessl D, Engle K, Leehey MA, Bounds LS, Paulich MJ, Hagerman RJ, Hagerman PJ, Cogswell JB, Tassone F, Reynolds A, Kooken R, Kenny M, Grigsby J.

J Clin Exp Neuropsychol. 2008 Nov;30(8):853-69. doi: 10.1080/13803390701819044. Epub 2008 Feb 15.

47.

Acceptability of telepsychiatry in American Indians.

Shore JH, Brooks E, Savin D, Orton H, Grigsby J, Manson SM.

Telemed J E Health. 2008 Jun;14(5):461-6. doi: 10.1089/tmj.2007.0077.

48.

The impact of executive cognitive functioning on rates of smoking cessation in the San Luis Valley Health and Aging Study.

Brega AG, Grigsby J, Kooken R, Hamman RF, Baxter J.

Age Ageing. 2008 Sep;37(5):521-5. doi: 10.1093/ageing/afn121. Epub 2008 May 30.

PMID:
18515287
49.

Dementia in fragile X-associated tremor/ataxia syndrome (FXTAS): comparison with Alzheimer's disease.

Seritan AL, Nguyen DV, Farias ST, Hinton L, Grigsby J, Bourgeois JA, Hagerman RJ.

Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1138-44. doi: 10.1002/ajmg.b.30732.

50.

Expanded clinical phenotype of women with the FMR1 premutation.

Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, Bronsky HE, Yuhas J, Borodyanskaya M, Grigsby J, Doerflinger M, Hagerman PJ, Hagerman RJ.

Am J Med Genet A. 2008 Apr 15;146A(8):1009-16. doi: 10.1002/ajmg.a.32060.

Supplemental Content

Loading ...
Support Center